Keywords: Advargraf, CellCept, Astellas, Rochem Organ rejection, Kidney transplant

Combination of Advagraf and CellCept led to less organ rejection; study

Article | 31 July 2011

Print This

For the thousands of patients who receive kidney transplants in the USA each year, preventing organ rejection without compromising other ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in